Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Twenty-five patients with hand
tremor
of 2+ (moderate) to 4+ (severe) on the
tremor
severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (
Allergan
, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If patients failed to respond to the initial injection, they were eligible to receive another injection of 100 U 4 weeks later. Rest, postural, and kinetic tremors were evaluated at 2- to 4-week intervals over a 16-week study period using
tremor
severity rating scales, accelerometry, and assessments of improvement and disability. A significant improvement (p < 0.05) was observed on the
tremor
severity rating scale 4 weeks after injection in patients treated with BTX as compared with placebo, and this effect was maintained for the duration of the study. Four weeks after injection, 75% of BTX-treated patients vs. 27% of placebo-treated patients (p < 0.05) reported mild to moderate improvement (peak effect rating > or = 2). There were no significant improvements in functional rating scales, although trends were observed for some items. Postural accelerometry measurements showed a > or = 30% reduction in amplitude in nine of 12 BTX-treated subjects and in one of nine placebo-treated subjects (p < 0.05). Although all patients treated with BTX reported some degree of finger weakness, no severe, irreversible, or unexpected adverse events occurred. Chemodenervation with BTX may significantly ameliorate essential hand
tremor
in patients who fail to improve with conventional pharmacologic therapy.
...
PMID:A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. 872 40
The authors present a very rare case of Holmes
tremor
(previously known as rubral or midbrain
tremor
). In all described till now cases the
tremor
was due to a known and revealed in laboratory or neuroimaging cause. We present an unusual case of a 42-year old woman with unilateral
tremor
of right extremities (mostly proximal part of upper extremity) which started abruptly 3 years ago. She had no suffer any serious disease before the onset of symptoms and her family history was also negative. The
tremor
was present at rest but accelerated during specific postures and active movements. The laboratory tests including: copper and ceruloplasmin concentrations, blood analysis for acanthocytes, evoked potentials, EEG, CT, MRI, MRA and SPECT did not reveal any significant changes. Treatment attempts with neuroleptics, clonazepam, L-dopa, valproic acid, biperiden were almost completely ineffective except local injections of botulinum toxin (Botox,
Allergan
, 150 U) into the muscles of right arm girdle which moderately alleviated
tremor
. We did not find any underlying pathology as a cause of
tremor
, clinically the same as symptomatic cases described in literature. We suggest the possibility of idiopathic origin of
tremor
in our case, although a very small size of lesion (f.i. ischaemic) could be undetectable in the described tests.
...
PMID:[Rubral tremor of Holmes, rare case of pathological tremor: case report]. 1110 9